Key result
Multi-omics integration of epigenetic mechanisms highlights novel biomarker and therapeutic targets in heart failure.
Answers are grounded in this paper and cite their sources.
The number of "omics" approaches is continuously growing. Among others, epigenetics has appeared as an attractive area of investigation by the cardiovascular research community, notably considering its association with disease development. Complex diseases such as cardiovascular diseases have to be tackled using methods integrating different omics levels, so called "multi-omics" approaches. These approaches combine and co-analyze different levels of disease regulation. In this review, we present and discuss the role of epigenetic mechanisms in regulating gene expression and provide an integrated view of how these mechanisms are interlinked and regulate the development of cardiac disease, with a particular attention to heart failure. We focus on DNA, histone, and RNA modifications, and discuss the current methods and tools used for data integration and analysis. Enhancing the knowledge of these regulatory mechanisms may lead to novel therapeutic approaches and biomarkers for precision healthcare and improved clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Sopić et al. (2023) conducted a review in Heart failure and cardiovascular disease. Epigenetic regulatory mechanisms (DNA, histone, and RNA modifications) and multi-omics integration was evaluated. Epigenetic regulatory mechanisms (DNA, histone, and RNA modifications) integrated via multi-omics approaches regulate gene expression in heart failure and may yield novel biomarkers and therapies.
Synapse has enriched 10 related papers. Consider them for comparative context: